Clinical, sociodemographic, and service provider determinants of guideline concordant colorectal cancer care for appalachian residents

Journal of Rural Health

Volumn 30, Issue 1, 2014, Pages 27-39

  Fleming, Steven T ^a   Mackley, Heath B ^b   Camacho, Fabian ^b   Seiber, Eric E ^c   Gusani, Niraj J ^b   Matthews, Stephen A ^d   Liao, Jason ^b   Yang, Tse Chuan ^d   Hwang, Wenke ^b   Yao, Nengliang ^d  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cancer; Demography; Epidemiology; Health disparities; Medicare

Indexed keywords

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMAN; MALE; MEDICARE; PRACTICE GUIDELINE; SOCIOECONOMICS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APPALACHIAN REGION; COLORECTAL NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HUMANS; KENTUCKY; MALE; MEDICARE; NORTH CAROLINA; OHIO; PENNSYLVANIA; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84891561726     PISSN: 0890765X     EISSN: 17480361     Source Type: Journal    
DOI: 10.1111/jrh.12033     Document Type: Article

References (56)

1. Lengerich EJ, Tucker TC, Powell RK, et al. Cancer incidence in Kentucky, Pennsylvania, and West Virginia: disparities in Appalachia. J Rural Health. 2005;21:39-47.
2. Appalachian Regional Commission. 2012. The Appalachian region. Available at: http://www.arc.gov/appalachian_region/TheAppalachianRegion.asp. Accessed February 23, 2012.
3. Appalachian Regional Commission. 2004. An analysis of disparities in health status and access to health care in the Appalachian region. Available at: http://www.etsu.edu/health/index_files/halversonreport.pdf. Accessed March 21, 2012.
4. Armstrong LR, Thompson T, Hall HI, et al. Colorectal carcinoma mortality among Appalachian men and women, 1969-1999. Cancer. 2004;101:2851-2858.
5. Cooper GS, Kou TD, Reynolds HL. Receipt of guideline-recommended follow-up in older colorectal cancer survivors. Cancer. 2008;113:2029-2037.
6. Chung-Yuan H, Delclos GL, Chan W, Du XL. Post-treatment surveillance in a large cohort of patients with colon cancer. Am J Manag Care. 2011;17:329-336
7. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Nat Canc Inst. 2007;99:433-441.
8. Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20, 898 patients on 18 randomized trials. J Clin Oncol. 2009;27:872-877.
9. Camma C, Giunta M, Fiorica F. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. J Am Med Assoc. 2000;284:1008-1015.
10. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer: why we still don't know. J Am Med Assoc. 1988;259:3571-3578.
11. Chagpar R, Xing Y, Chiang Y, et al. Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol. 2012;30:972-979.
12. Haas JS, Brawarsky P, Iyer A, Fitzmaurice GM, Neville BA, Earle C. Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality. Cancer. 2011:117:4267-4276.
13. Hao Y, Landrine H, Jemal A, et al. Race, neighborhood characteristics and disparities in chemotherapy for colorectal cancer. J Epidemiol Commun Health 2011:65:211-217.
14. Cueto CV, Szeja S, Wertheim BC, Ong ES, Tsikitis VL. Disparities in treatment and survival of white and Native American patients with colorectal cancer: a SEER analysis. J Am Coll Surg. 2011;213:469-474.
15. Hines RB, Markossian TW. Differences in late-stage diagnosis, treatment, and colorectal cancer-related death between rural and urban african americans and whites in Georgia. J Rural Health. 2012;28:296-305.
16. Esnaola NF, Gebregziabher M, Finney C, Ford ME. Underuse of surgical resection in black patients with nonmetastatic colorectal cancer. Ann Surg. 2009;250:549-557.
17. Commission on Cancer. The Rapid Quality Reporting System (RQRS). Chicago, Illinois; 2011. Available at: http://www.facs.org/cancer/ncdb/rqrs.html. Accessed May 9, 2013.
18. National Quality Forum. National Voluntary Consensus Standards for Quality of Cancer Care: A Concensus Report. Washington, DC. 2009. Available at: http://www.qualityforum.org/Publications/2009/05/National_Voluntary_Consensus_Standards_for_Quality_of_Cancer_Care.aspx. Accessed May 9, 2013.
19. Colon cancer measures submitted by the CoC to the National Quality Forum (NQF) and endorsed by the NQF in April 2007. Available at: http://www.facs.org/cancer/ncdb/colonmeasures.pdf. Accessed May 9, 2013.
20. Rectal cancer measure developed collaboratively by the CoC and ASCO/NCCN. Available at: http://www.facs.org/cancer/ncdb/rectalmeasure.pdf. Accessed May 9, 2013.
21. Fleming ST, Sabatino SA, Kimmick G, et al. for the Patterns of Care Study Group. Developing a claim-based version of the ACE-27 comorbidity index: a comparison with medical record review. Med Care. 2011;49:752-760.
22. USDA 2000 Rural-Urban Continuum Codes. Available at: http://www.ers.usda.gov/Briefing/Rurality/RuralUrbanCommutingAreas. Accessed May 9, 2013.
23. American College of Surgeons. Available at: http://www.facs.org/cancerprogram/index.html. Accessed June 11, 2013.
24. National Plan & Provider Enumeration System. Available at: https://nppes.cms.hhs.gov/NPPESRegistry/NPIRegistryHome.do. Accessed June 11, 2013.
25. Health Grades. Available at: www.healthgrades.com/. Accessed June 11, 2013.
26. ECARE UPIN Lookup. Available at: http://upin.ecare.com/. Accessed June 11, 2013.
27. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
28. Schafer JL. Analysis of Incomplete Multivariate Data. New York: Chapman and Hall; 1997.
29. Jonathan W, Forst C, Carpenter JR. Multiple imputation models should incorporate the outcome in the model of interest. Brain. 2011;134: e189.
30. Moons KG, Donders RA, Stijnen T, et al. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol. 2006;59:1092-1101.
31. Ake CF. Rounding after multiple imputation with non-binary categorical covariates. Paper presented at the annual Meeting of the SAS Users Group International, Philadelphia, PA; 2005.
32. Allison PD. Imputation of Categorical Variables with PROC MI. Paper Presented at the Annual Meeting of the Sas Users Group International. Philadelphia, PA; 2005.
33. Breslow NE, Clayton DG. Approximate inference in generalized linear mixed models. J Am Stat Assoc. 1993;88:9-25. doi:10.2307/2290687.JSTOR2290687.
34. American Cancer Society. Cancer Facts and Figures 2012. Atlanta: American Cancer Society; 2012.
35. Sinclair AH, Schymura MJ, Boscoe FP, et al. Measur-ing colorectal cancer care quality for the publicly insured in New York State. Cancer Med. 2012 1(3):363-371.
36. Jackson GL, Melton LD, Abbott DH, et al. Quality of nonmetastatic colorectal cancer care in the department of veterans affairs. J Clin Oncol. 2010;28:3176-3181.
37. Romanus D, Weiser MR, Skibber JM, et al. Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: an NCCN institutional analysis. J Natl Comprehen Cancer Network. 2009;7:895-904.
38. Parsons HM, Tuttle TM, Kuntz KM, et al. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011;306:1089-1097.
39. Cress RD, Sabatino SA, Wu X, et al. Adjuvant chemotherapy for patients with stage III colon cancer: results from a CDC-NPCR Patterns of Care Study. Clin Med: Oncol. 2009; 3:107-119.
40. Hsu CW, Lin CH, Wang JH, Wang HT, Ou WC, King TM. Factors that influence 12 or more harvested lymph nodes in early-stage colorectal cancer. World J Surg. 2009;33:333-339.
41. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Instit. 2005;97(3):219-225.
42. Hu CY, Delclos GL, Chan W, et al. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer. Med Oncol. 2011;28:1062-1074.
43. Chang GJ, Skibber JM, Feig BW, et al. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007;246:215-221.
44. Chou JF, Row D, Gonen M, et al. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer. 2010;116:2560-2570.
45. Romano P, Mark D. Bias in the coding of hospital discharge data and it implications for quality assessment. Med Care. 1994;32:81-90.
46. Steinwachs D, Stuart M, Scholle S, Starfield B, Fox M, Weiner J. A comparison of ambulatory medicaid claims to medical records: a reliability assessment. Am J Med Qual. 1998;13:63-69.
47. Dismuke C. Underreporting of computed tomography and magnetic resonance imaging procedures in inpatient claims data. Med Care. 2005;43:713-717.
48. Bright R, Avorn J, Everitt D. Medicaid data as a resource for epidemiologic studies: strengths and weaknesses. J Clin Epidemiol. 1989;42:937-945.
49. Quan H, Parsons G, Ghali W. Validity of procedure codes in international classification of diseases, 9th revision, clinical modification administrative data. Med Care. 2004;42:801-809.
50. Romano P. Using administrative data to identify associations between implanted medical devices and chronic diseases. Ann Epidemiol 2000;10:197-199.
51. Tyree P, Lind B, Lafferty W. Challenges of using medical insurance claims data for utilization analysis. Am J Med Qual. 2006;21:269-275.
52. Cooper G, Yuan Z, Stange K, Dennis L, Amini S, Rimm A. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Med Care. 2000;38:411-421.
53. Pinfold P, Goel V, Sawka C. Quality of hospital discharge and physician data for type of breast cancer surgery. Med Care. 2000; 38:99-107.
54. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005;58:323-337.
55. Warren JL, Harlan LC. Can cancer registry data be used to study cancer treatment? Med Care. 2003;41:1003-1005.
56. Cress RD, Zaslavsky AM, West DW, et al. Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care. 2003;41:1006-1012.